DOCSLIB.ORG

P528000-Gentaur-Products.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
P528000-Gentaur-Products.Pdf Chapter 2 : Gentaur Products List • alpha methyl N N bis 4 1 phenylethyl p alpha methyl N N phenylpiperidine • alsactide alsactide bis 4 • alpha phenylpyridine 2 ethanol alpha phenylpyridine 2 • Altertoxin I Dihydroalterperylenol Altertoxin • alpha methyl N N diphenylbenzylamine alpha methyl N N • alpha phosphinylbenzyl alcohol alpha phosphinylbenzyl • Altizide Altizide diphe • alpha Phosphoglucomutase alpha Phosphoglucomu • Altrenogest Altrenogest • alpha methylnaphthalene 1 acetonitrile alpha • 1810 • Alumina gamma Aluminium oxid methylnaphthale • alpha Picolinamide alpha Picolinamide • aluminium 1 methylethyl naphthalenesul aluminium 1 • alpha methyl n phenyl 1h benzotriazole alpha methyl n • alpha Picoline N oxide alpha Picoline N oxide methyleth phenyl • Alpha Picolinic acid ethyl ester Alpha Picolinic acid eth • aluminium Z hexadec 9 enoate aluminium Z hexadec • alpha methyl N phenyl N 4 1 phenyleth alpha methyl N • alpha Pineneoxide alpha Pineneoxide • aluminium 1 methylnaphthalenesulphon aluminium 1 phenyl • alphaprodine alphaprodine methylnap • alpha Methylornithine hydrochloride alpha Methylornithine • Alphaprodine hydrochloride CII Alphaprodine hydrochlo • aluminium 2 methylpropanolate aluminium 2 methylpro h • alpha propoxyphenethyl alcohol alpha propoxyphenethy • aluminium 3 4 anilinophenyl azo benze aluminium 3 4 • alpha Methyl p anisyl alcohol alpha Methyl p anisyl al • alpha propylcyclohexylmethyl acetate alpha anilino • alpha methylphenethyl acetate alpha methylphenethyl propylcyclohexyl • aluminium 3 acetoxy 11 oxoolean 2 en aluminium 3 • alpha methylphenethyl isothiocyanate alpha • alpha Propyldopacetamide alpha Propyldopacetam acetoxy 1 methylphenethyl i • alpha Pyrone Pyrone alpha • aluminium 3 hydroxynaphthalene 2 7 dis aluminium 3 • alpha methylphenethylamine alpha methylphenethyla • alpha Santalene alpha Santalene hydroxyna • alpha methylphenethylammonium R R alpha • Alpha Selinene Alpha Selinene • aluminium 4 1 1 dimethylethyl benzoate aluminium 4 1 1 methylphenethyla • alpha Sinensal alpha Sinensal dimet • alpha methylpiperazine 1 ethanol alpha methylpiperazine • alpha Solanine alpha Solanine • Aluminium acetylacetonate Aluminium 2 4 pentane • alpha methylpiperidine 1 ethylamine alpha • alpha Sophorose a Sophorose • Aluminium acrylate Aluminium acrylate methylpiperidine • Alpha sulfophenylacetic acid Alpha sulfophenylacetic • aluminium barium silicate 2 1 2 aluminium barium silica • alpha methylpyridine 2 methanol alpha methylpyridine 2 • alpha Terpinen alpha Terpinen • Aluminium borate Aluminium borate • alpha methylpyridine 3 methanol alpha methylpyridine 3 • alpha tert butyl E beta cyclohexylmeth alpha tert butyl E bet • Aluminium boride Aluminium boride • alpha methylpyridine 4 methanol alpha methylpyridine 4 • alpha tert butyl R E beta cyclohexyl alpha tert butyl R E • Aluminium bromide anhydrous Aluminium tribromide • alpha methylpyrrolidine 1 ethanol alpha methylpyrrolidine • alpha tert butyl S E beta cyclohexyl alpha tert butyl S E • aluminium bromide dihydroxide aluminium bromide dihy • alpha Methylstilbene alpha Methylstilbene • alpha tert butyl alpha 4 chlorophenoxy alpha tert butyl • Aluminium bromide hexahydrate for anal Aluminium • alpha Methylstyrene Isopropenylbenzene alpha bromide 6H • alpha Methylstyrene dimer alpha Methylstyrene di • alpha tert butyl beta cyclohexylmethylen alpha tert butyl • aluminium caesium bis sulphate aluminium caesium bis • Alphamethylthio 4 chloro acetophenone beta cy • aluminium calcium silicate 2 1 2 aluminium calcium silic • 1809 • alpha tert butyl beta 2 4 dichlorophenyl alpha tert butyl beta • Aluminium carbide metals basis • alpha methylthiophen 2 ethanol alpha methylthiophen 2 2 • Aluminium carbonate basic Aluminium carbonate b • alpha methylthiophene 2 methanol alpha methylthiophene • alpha tert butyl beta 4 chlorophenyl me alpha tert butyl beta • Aluminium cement Aluminium cement • Alpha methyltryptamine methanesulfonat Alpha 4 • aluminium cerium trioxide aluminium cerium trioxi methyltryptamine • alpha Tetralol alpha Tetralol • aluminium chlorate aluminium chlorate • alpha Muricholic acid 3a 6b 7a Trihydroxy 5b • alpha Tetralone Tetralone alpha • aluminium chloride dihydroxide aluminium chloride dihy • alpha naphthoflavone 7 8 Benzoflavone • alpha Thujene alpha Thujene • Aluminium chloride hexahydrate Aluminumchloride 6H2 • alpha Naphthoic acid carboxy 14C alpha Naphthoic acid c • alpha thymidine crystalline alpha thymidine crystall • aluminium chloridephosphate aluminium chloridephos • alpha Naphthol orange alpha Naphthol Orange • alpha Tocophenyl nicotinate alpha Tocophenyl nicoti • Aluminium citrate Aluminium citrate • Alpha naphtholbenzein Bis 4 hydroxy 1 napht • alpha Tocopherol Vitamin E • aluminium copper dioxide aluminium copper dioxi • Alpha Naphtholphthalein Alpha Naphtholphthalei • alpha Tocopherol calcium succinate Vitamin E calcium • Aluminium di isopropoxide acetoacetic e Al 9 6 min • alpha Naphthyl laurate crystalline alpha Naphthyl laurate succi • 1812 • alpha Naphthyl palmitate alpha Naphthyl palmitat • alpha Tocopherol linoleate alpha Tocopherol linole • Aluminium di sec butoxide acetoacetic e technical grade Al • alpha Naphthyl red hydrochloride alpha Naphthyl red HCl • alpha Tocopheryl linoleate Vitamin E linoleate 8 4 • alpha naphthyl stearate crystalline alpha naphthyl stearate • alpha Tocopheryl nicotinate Vitamin E nicotinate • aluminium dicalcium iron pentaoxide aluminium dicalcium • Alpha naphthyl sulfate potassium salt cry Alpha naphthyl • alpha Tocopheryl palmitate Vitamin E palimitate iro sulfate • alpha Tocotrienol Tocotrienol alpha • aluminium dichloride hydroxide aluminium dichloride hy • alpha Neoendorphin from porcine alpha neoendorphin fro • alpha Toluenesulfonamide alpha Toluenesulfonam • Aluminium diformate Aluminium diformate • alpha N Ethyl 1 naphthylamine hydrobro N Ethyl 1 • alpha Tosyl 2 3 difluorobenzyl isocyanid alpha Tosyl 2 3 • Aluminium dihydrogen triphosphate Aluminium dihydrogen naphthylamin difluor t • alpha n Ethyl 1 naphthylamine hydrochlo n ethyl 1 • alpha Tosyl 2 4 difluorobenzyl isocyanid alpha Tosyl 2 4 • Aluminium diiron tetraoxide Aluminium diiron tetrao naphthylamin difluor • aluminium dimagnesium heptahydroxide aluminium • alpha Nicotinamide adenine dinucleotide Coenzyme 1 • alpha Tosyl 2 5 difluorobenzyl isocyanid alpha Tosyl 2 5 dimagnesiu • alpha Nicotyrine Nicotyrine alpha difluor • Aluminium dimethyl chloride Dimethyl aluminium chl • alpha Nitrotoluene Alpha Nitrotoluene • alpha Tosyl 2 6 difluorobenzyl isocyanid alpha Tosyl 2 6 • Aluminium distearate Aluminium distearate • alpha Olefin C14 C16 sulfonated sodiu alpha Olefin C14 difluor • aluminium dodecaboride aluminium dodecaborid C16 • alpha Tosyl 2 methoxybenzyl isocyanid alpha Tosyl 2 • aluminium dodecyl sulphate aluminium dodecyl sulp • alpha Oxo 1H indole 3 acetyl chloride alpha Oxo 1H indole methoxy • Aluminium dodecylbenzenesulphonate Aluminium 3 • alpha Tosyl 3 4 5 trimethoxylbenzyl isoc alpha Tosyl 3 4 5 dodecylbenz • alpha Oxo 2 furanacetonitrile alpha Oxo 2 furanacet trim • aluminium dysprosium trioxide aluminium dysprosium t • alpha Oxo 3 furanacetic acid alpha Oxo 3 furanaceti • alpha Tosyl 3 4 dichlorolbenzyl isocyani alpha Tosyl 3 4 • aluminium erbium trioxide aluminium erbium trioxi • alpha Oxo 3 thiopheneacetic acid alpha Oxo 3 thiophene dichlor • aluminium europium trioxide aluminium europium tri • alpha oxocyclohexaneacetic acid alpha oxocyclohexanea • alpha Tosyl 3 4 difluorobenzyl isocyanid alpha Tosyl 3 4 • Aluminium fluoride Puratronic • alpha oxofuran 2 acetamide alpha oxofuran 2 aceta difluor • Aluminium gadolinium trioxide Aluminium gadolinium t • alpha oxofuran 2 acetic acid alpha oxofuran 2 acetic • alpha Tosyl 3 iodomethylbenzyl isocyan alpha Tosyl 3 • Aluminium glycinate • alpha oxopyridine 4 acetonitrile alpha oxopyridine 4 ac iodomet • aluminium heptadecanoate aluminium heptadecan • alpha oxothiophen 2 acetonitrile alpha oxothiophen 2 ac • alpha Tosyl 3 trifluoromethylbenzyl isoc alpha Tosyl 3 • aluminium heptan 1 olate aluminium heptan 1 ola • alpha pentylfuran 2 methanol alpha pentylfuran 2 me trifluoro • aluminium hexadecan 1 olate aluminium hexadecan • alpha Phenyl 1 2 phenylethyl 4 piperidi MDL 11 939 • alpha Tosyl 4 iodomethylbenzyl isocyan alpha Tosyl 4 • Aluminium hexafluoro 2 4 pentanedionat Aluminium • alpha phenyl 1 3 5 7 tetraazatricyclo 3 3 alpha phenyl 1 3 5 iodomet hexafluoro 2 7 tet • alpha Tosyl 4 trifluoromethylbenzyl isoc alpha Tosyl 4 • Aluminium hexafluorosilicate Aluminium hexafluorosi • alpha phenyl 1H benzimidazole 2 metha alpha phenyl 1H trifluoro • aluminium holmium trioxide aluminium holmium trio benzi • alpha Tosylbenzyl isocyanide alpha Tosylbenzyl isocy • Aluminium hydride Aluminium trihydride • alpha phenyl alpha 3 1 pyrrolidinyl pro alpha phenyl alpha • 1811 • aluminium hydroxide oxide aluminium hydroxide ox 3 • Alpha trans Bergamotene Alpha trans Bergamote • aluminium hydroxide sulphate aluminium hydroxide su • alpha phenyl alpha 2 thienylmorpholinep alpha phenyl • alpha Trifluoromethylcrotonic acid alpha Trifluoromethylcr • aluminium hydroxydimethylbenzenesulp aluminium alpha 2 th • alpha trifluoromethyl gamma bu alpha trifluoromethyl ga hydroxydime • alpha phenylaziridine 1 ethanol alpha phenylaziridine 1 • alpha vinylbenzyl acetate alpha vinylbenzyl acetat • aluminium hydroxymethylbenzenesulpho aluminium • alpha Phenylbutyr amide alpha Phenylbutyr amid • Alphaxalone Alphaxalone hydroxymeth • alpha Phenylcinnamic acid a Phenylmethylene b • alpha Zearalenol alpha
Load more

Recommended publications
  • Relationship Between the Conformation of the Cyclopeptides Isolated from the Fungus Amanita Phalloides (Vaill. Ex Fr.) Secr. and Its Toxicity
    Molecules 2000, 5 489 Relationship Between the Conformation of the Cyclopeptides Isolated from the Fungus Amanita Phalloides (Vaill. Ex Fr.) Secr. and Its Toxicity M.E. Battista, A.A. Vitale and A.B. Pomilio PROPLAME-CONICET, Departamento de Química Orgánica, Facultad de Ciencias Exactas y Natu- rales, Universidad de Buenos Aires, Pabellón 2, Ciudad Universitaria, 1428 Buenos Aires, Argentina E-mail: [email protected] Abstract: The electronic structures and conformational studies of the cyclopeptides, O- methyl-α-amanitin, phalloidin and antamanide, were obtained from molecular parameters on the basis of semiempiric and ab initio methods. Introduction During this century Amanita phalloides - the most toxic fungus known up to now - has been studied from different points of view. This basidiomycete biosynthesizes mono- and bicyclic peptides com- posed of rare amino acids. In order to determine the structure/activity relationships chemical modifica- tions were carried out and the properties of these compounds were evaluated. These results were con- firmed by studying the conformations of three selected compounds representative of the major groups of the macroconstituents of this fungus. Experimental Hyperchem package (HyperCube, version 5.2) was used for semiempirical studies, the molecular geometry being optimized by STO-631G. Net charges were calculated with HyperCube PM3 and the Polack-Ribiere algoritm. GAUSSIAN 98 was used for ab initio studies. Results and Discussion We were interested in obtaining information on the conformations that the cyclic peptides may adopt and about the potential energy maps in order to locate the regions related to the binding to pro- tein molecules, such as F-actin and RNA-polymerase.
    [Show full text]
  • Commission Implementing Regulation (EU)
    21.3.2013 EN Official Journal of the European Union L 80/1 II (Non-legislative acts) REGULATIONS COMMISSION IMPLEMENTING REGULATION (EU) No 230/2013 of 14 March 2013 on the withdrawal from the market of certain feed additives belonging to the group of flavouring and appetising substances (Text with EEA relevance) THE EUROPEAN COMMISSION, submitted before that deadline for the only animal category for which those feed additives had been auth­ orised pursuant to Directive 70/524/EEC. Having regard to the Treaty on the Functioning of the European Union, (4) For transparency purposes, feed additives for which no applications for authorisation were submitted within the Having regard to Regulation (EC) No 1831/2003 of the period specified in Article 10(2) of Regulation (EC) No European Parliament and of the Council of 22 September 1831/2003 were listed in a separate part of the 2003 on additives for use in animal nutrition ( 1 ), and in Community Register of Feed Additives. particular Article 10(5) thereof, (5) Those feed additives should therefore be withdrawn from Whereas: the market as far as their use as flavouring and appetising substances is concerned, except for animal species and categories of animal species for which applications for (1) Regulation (EC) No 1831/2003 provides for the auth­ authorisation have been submitted. This measure does orisation of additives for use in animal nutrition and not interfere with the use of some of the abovemen­ for the grounds and procedures for granting such auth­ tioned additives according to other animal species or orisation. Article 10 of that Regulation provides for the categories of animal species or to other functional re-evaluation of additives authorised pursuant to Council groups for which they may be allowed.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Withdrawing Benzodiazepines in Primary Care
    PC\/ICU/ ADTiriC • CNS Drugs 2009,-23(1): 19-34 KtVltW MKIIWLC 1172-7047/I»/O(X)1«119/S4W5/C1 © 2009 Adis Dato Intocmation BV. All rights reserved. Withdrawing Benzodiazepines in Primary Care Malcolm Luder} Andre Tylee^ and ]ohn Donoghue^ 1 Institute of Psychiatry, King's College London, London, England 2 John Moores University, Liverpool, Scotland Contents Abstract ' 19 1. Benzodiazepine Usage 22 2. Interventions 23 2.1 Simple interventions 23 2.2 Piiarmacoiogicai interventions 25 2.3 Psychoiogical Interventions 26 2.4 Meta-Anaiysis ot Various interventions 27 3. Outcomes 28 4. Practicai Issues 29 5. Otiier Medications 30 5.1 Antidepressants 30 5.2 Symptomatic Treatments 30 6. Conciusions 31 Abstract The use of benzodiazepine anxiolytics and hypnotics continues to excite controversy. Views differ from expert to expert and from country to country as to the extent of the problem, or even whether long-term benzodiazepine use actually constitutes a problem. The adverse effects of these drugs have been extensively documented and their effectiveness is being increasingly questioned. Discontinua- tion is usually beneficial as it is followed by improved psychomotor and cognitive functioning, particularly in the elderly. The potential for dependence and addic- tion have also become more apparent. The licensing of SSRIs for anxiety disorders has widened the prescdbers' therapeutic choices (although this group of medications also have their own adverse effects). Melatonin agonists show promise in some forms of insomnia. Accordingly, it is now even more imperative that long-term benzodiazepine users be reviewed with respect to possible discon- tinuation. Strategies for discontinuation start with primary-care practitioners, who are still the main prescdbers.
    [Show full text]
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Test Items for Licensing Examination Krok 1 PHARMACY
    MINISTRY OF PUBLIC HEALTH OF UKRAINE Department of human resources policy, education and science Testing Board Student ID Last name Variant ________________ Test items for licensing examination Krok 1 PHARMACY (російськомовний варіант) General Instruction Every one of these numbered questions or unfinished statements in this chapter corresponds to answers or statements endings. Choose the answer (finished statements) that fits best and fill in the circle with the corresponding Latin letter on the answer sheet. Authors of items: Abramov A.V., Aleksandrova K.V., Andronov D.Yu., Bilyk O.V., Blinder O.O., Bobyr V.V., Bobrovska O.A., Bohatyriova O.V., Bodnarchuk O.V., Boieva S.S., Bolokhovska T.O., Bondarenko Yu.I., Bratenko M.K., Buchko O.V., Cherneha H.V., Davydova N.V., Deriuhina L.I., Didenko N.O., Dmytriv A.M., Doroshkevych I.O., Dutka N.M., Dynnyk K.V., Filipova L.O., Havryliuk I.M., Herhel T.M., Hlushkova O.M., Hozhdzinsky S.M., Hrekova T.A., Hrechana O.V., Hruzevsky O.A., Hudyvok Ya.S., Hurmak I.S., Ivanets L.M., Ivanov Ye.I., Kartashova T.V., Kava T.V., Kazakova V.V., Kazmirchuk H.V., Kernychna I.Z., Khlus K.M., Khmelnykova L.I., Klebansky Ye.O., Klopotsky H.A., Klymniuk S.I., Kobylinska L.I., Koldunov V.V., Kolesnyk V.P., Kolesnikova T.O., Komlevoy O.M., Kononenko N.M., Kornijevsky Yu.Y., Kremenska L.V., Krushynska T.Yu., Kryzhanovska A.V., Kryshtal M.V., Kukurychkin Ye.R., Kuznietsova N.L., Kuzmina A.V., Lisnycha A.M., Lychko V.H., Makats Ye.F., Maly V.V., Matvijenko A.H., Menchuk K.M., Minarchenko V.M., Mikheiev A.O., Mishchenko
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Pharmacological Properties of GABAA- Receptors Containing Gamma1
    Molecular Pharmacology Fast Forward. Published on November 4, 2005 as DOI: 10.1124/mol.105.017236 Molecular PharmacologyThis article hasFast not Forward.been copyedited Published and formatted. on The November final version 7, may 2005 differ as from doi:10.1124/mol.105.017236 this version. MOLPHARM/2005/017236 Pharmacological properties of GABAA- receptors containing gamma1- subunits Khom S.1, Baburin I.1, Timin EN, Hohaus A., Sieghart W., Hering S. Downloaded from Department of Pharmacology and Toxicology, University of Vienna Center of Brain Research , Medical University of Vienna, Division of Biochemistry and molpharm.aspetjournals.org Molecular Biology at ASPET Journals on September 27, 2021 1 Copyright 2005 by the American Society for Pharmacology and Experimental Therapeutics. Molecular Pharmacology Fast Forward. Published on November 4, 2005 as DOI: 10.1124/mol.105.017236 This article has not been copyedited and formatted. The final version may differ from this version. MOLPHARM/2005/017236 Running Title: GABAA- receptors containing gamma1- subunits Corresponding author: Steffen Hering Department of Pharmacology and Toxicology University of Vienna Althanstrasse 14 Downloaded from A-1090 Vienna Telephone number: +43-1-4277-55301 Fax number: +43-1-4277-9553 molpharm.aspetjournals.org [email protected] Text pages: 29 at ASPET Journals on September 27, 2021 Tables: 2 Figures: 7 References: 26 Abstract: 236 words Introduction:575 words Discussion:1383 words 2 Molecular Pharmacology Fast Forward. Published on November 4, 2005 as DOI: 10.1124/mol.105.017236 This article has not been copyedited and formatted. The final version may differ from this version. MOLPHARM/2005/017236 Abstract GABAA receptors composed of α1, β2, γ1-subunits are expressed in only a few areas of the brain and thus represent interesting drug targets.
    [Show full text]
  • International Journal of Pharma and Bio Sciences ISSN 0975-6299 1,5
    Int J Pharm Bio Sci 2013 July; 4(3): (P) 345 - 370 Review Article Medicinal Chemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 1,5-BENZODIAZEPINE: A VERSATILE PHARMACOPHORE P.S. SALVE* AND D.S. MALI Department of Pharmaceutical Chemistry, KLE University’s College of Pharmacy, Belgaum, Karnataka, India. ABSTRACT Diazepines are an eminent class of drugs owing to their psychotherapeutic activities. Among these, 1,5-benzodiazepines are regarded as privileged structures due to their clinical importance and commercial success. Although immense work has been carried out on the benzodiazepine nucleus, it continues to receive a great deal of attention. Due to their vast range of biological properties the benzodiazepine nucleus has fascinated many investigators to synthesize and screen the analogues for all possible activities through all possible routes. This current review article mainly covers the various routes of synthesis utilized, the numerous solvents employed, catalysts used and the different pharmacological activities exhibited by 1,5-benzodiazepine derivatives. This review encompasses the research work that has been accomplished since the past decade. KEYWORDS: 1,5-Benzodiazepines, o-Phenylenediamines, Synthesis, Catalyst, Diazepines P.S. SALVE Department of Pharmaceutical Chemistry, KLE University’s College of Pharmacy, Belgaum, Karnataka, India. *Corresponding author This article can be downloaded from www.ijpbs.net P - 345 Int J Pharm Bio Sci 2013 July; 4(3): (P) 345 - 370 INTRODUCTION Benzodiazepines are an important class of activities.1,2 They have also been used in nitrogen containing heterocyclic compounds treatment of viral diseases3,4, cardiovascular acting mainly on the central nervous system. disorders5 and as cholecystokinin (CCK) They have attracted much attention in the field receptor antagonists.6,7The 1,5-benzodiazepine of medicine and pharmaceuticals due to their scaffold is extremely versatile and has featured broad spectrum of biological activities.
    [Show full text]
  • 56 Subpart F—Flavoring Agents and Related Substances
    § 172.510 21 CFR Ch. I (4–1–12 Edition) needed to produce its intended effect (a) They are used in the minimum but not in excess of 13 parts per million quantity required to produce their in- calculated as anhydrous sodium ferro- tended physical or technical effect and cyanide. in accordance with all the principles of [42 FR 14491, Mar. 15, 1977, as amended at 58 good manufacturing practice. FR 17098, Apr. 1, 1993] (b) In the appropriate forms (plant parts, fluid and solid extracts, con- Subpart F—Flavoring Agents and centrates, absolutes, oils, gums, bal- Related Substances sams, resins, oleoresins, waxes, and dis- tillates) they consist of one or more of § 172.510 Natural flavoring substances the following, used alone or in com- and natural substances used in con- bination with flavoring substances and junction with flavors. adjuvants generally recognized as safe Natural flavoring substances and in food, previously sanctioned for such natural adjuvants may be safely used use, or regulated in any section of this in food in accordance with the fol- part. lowing conditions. Common name Scientific name Limitations Aloe ................................................................ Aloe perryi Baker, A. barbadensis Mill., A. ferox Mill., and hybrids of this sp. with A. africana Mill. and A. spicata Baker. Althea root and flowers .................................. Althea officinalis L. Amyris (West Indian sandalwood) ................. Amyris balsamifera L. Angola weed .................................................. Roccella fuciformis
    [Show full text]
  • Download S/2013/735
    United Nations A/68/663–S/2013/735 General Assembly Distr.: General 13 December 2013 Security Council Original: English General Assembly Security Council Sixty-eighth session Sixty-eighth year Agenda item 33 Prevention of armed conflict Identical letters dated 13 December 2013 from the Secretary-General addressed to the President of the General Assembly and the President of the Security Council I have the honour to convey herewith the final report of the United Nations Mission to Investigate Allegations of the Use of Chemical Weapons in the Syrian Arab Republic (see annex). I would be grateful if the present final report, the letter of transmittal and its appendices could be brought to the attention of the Members of the General Assembly and of the Security Council. (Signed) BAN Ki-moon 13-61784 (E) 131213 *1361784* A/68/663 S/2013/735 Annex Letter of transmittal Having completed our investigation into the allegations of the use of chemical weapons in the Syrian Arab Republic reported to you by Member States, and further to the report of the United Nations Mission to Investigate Allegations of the Use of Chemical Weapons in the Syrian Arab Republic (hereinafter, the “United Nations Mission”) on allegations of the use of the chemical weapons in the Ghouta area of Damascus on 21 August 2013 (A/67/997-S/2013/553), we have the honour to submit the final report of the United Nations Mission. To date, 16 allegations of separate incidents involving the use of chemical weapons have been reported to the Secretary-General by Member States, including, primarily, the Governments of France, Qatar, the Syrian Arab Republic, the United Kingdom of Great Britain and Northern Ireland and the United States of America.
    [Show full text]
  • RIFM Fragrance Ingredient Safety Assessment, Menthyl Isovalerate CAS Registry Number 16409-46-4
    Food and Chemical Toxicology 110 (2017) S486eS495 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Short review RIFM fragrance ingredient safety assessment, menthyl isovalerate CAS Registry Number 16409-46-4 * A.M. Api a, , D. Belsito b, D. Botelho a, D. Browne a, M. Bruze c, G.A. Burton Jr. d, J. Buschmann e, M.L. Dagli f, M. Date a, W. Dekant g, C. Deodhar a, M. Francis a, A.D. Fryer h, K. Joshi a,S.LaCavaa, A. Lapczynski a, D.C. Liebler i, D. O'Brien a, R. Parakhia a,A.Patela, T.M. Penning j, G. Ritacco a, J. Romine a, D. Salvito a, T.W. Schultz k, I.G. Sipes l, Y. Thakkar a, E.H. Theophilus a, A.K. Tiethof a, Y. Tokura m, S. Tsang a, J. Wahler a a Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA b Member RIFM Expert Panel, Columbia University Medical Center, Department of Dermatology, 161 Fort Washington Ave., New York, NY 10032, USA c Member RIFM Expert Panel, Malmo University Hospital, Department of Occupational & Environmental Dermatology, Sodra Forstadsgatan 101, Entrance 47, Malmo SE-20502, Sweden d Member RIFM Expert Panel, School of Natural Resources & Environment, University of Michigan, Dana Building G110, 440 Church St., Ann Arbor, MI 58109, USA e Member RIFM Expert Panel, Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany f Member RIFM Expert Panel, University of Sao Paulo, School of Veterinary Medicine and Animal Science, Department of Pathology, Av.
    [Show full text]